• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向糖胺聚糖在遗传和炎症性气道疾病中的作用。

Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease.

机构信息

Irish Centre for Genetic Lung Disease, Department of Medicine, RCSI University of Medicine and Health Sciences, Beaumont Hospital, D09 YD60 Dublin, Ireland.

出版信息

Int J Mol Sci. 2022 Jun 8;23(12):6400. doi: 10.3390/ijms23126400.

DOI:10.3390/ijms23126400
PMID:35742845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224208/
Abstract

In the lung, glycosaminoglycans (GAGs) are dispersed in the extracellular matrix (ECM) occupying the interstitial space between the capillary endothelium and the alveolar epithelium, in the sub-epithelial tissue and in airway secretions. In addition to playing key structural roles, GAGs contribute to a number of physiologic processes ranging from cell differentiation, cell adhesion and wound healing. Cytokine and chemokine-GAG interactions are also involved in presentation of inflammatory molecules to respective receptors leading to immune cell migration and airway infiltration. More recently, pathophysiological roles of GAGs have been described. This review aims to discuss the biological roles and molecular interactions of GAGs, and their impact in the pathology of chronic airway diseases, such as cystic fibrosis and chronic obstructive pulmonary disease. Moreover, the role of GAGs in respiratory disease has been heightened by the current COVID-19 pandemic. This review underlines the essential need for continued research aimed at exploring the contribution of GAGs in the development of inflammation, to provide a better understanding of their biological impact, as well as leads in the development of new therapeutic agents.

摘要

在肺部,糖胺聚糖 (GAGs) 分散在细胞外基质 (ECM) 中,占据毛细血管内皮细胞和肺泡上皮细胞之间的间质空间、位于上皮下组织和气道分泌物中。除了发挥关键的结构作用外,GAGs 还参与了许多生理过程,包括细胞分化、细胞黏附和伤口愈合。细胞因子和趋化因子-GAG 的相互作用也涉及到将炎症分子呈递给相应的受体,从而导致免疫细胞的迁移和气道浸润。最近,GAGs 的病理生理学作用也得到了描述。本综述旨在讨论 GAGs 的生物学作用和分子相互作用,以及它们在慢性气道疾病(如囊性纤维化和慢性阻塞性肺疾病)中的病理作用。此外,在当前的 COVID-19 大流行中,GAGs 在呼吸道疾病中的作用得到了提升。本综述强调了继续研究 GAGs 在炎症发展中的作用的必要性,以便更好地了解其生物学影响,并为开发新的治疗药物提供线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/3097e305aff4/ijms-23-06400-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/b2301f096cbf/ijms-23-06400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/edb5fc65fbd2/ijms-23-06400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/590fa4896533/ijms-23-06400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/3f678d6f17d2/ijms-23-06400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/3097e305aff4/ijms-23-06400-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/b2301f096cbf/ijms-23-06400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/edb5fc65fbd2/ijms-23-06400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/590fa4896533/ijms-23-06400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/3f678d6f17d2/ijms-23-06400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e74/9224208/3097e305aff4/ijms-23-06400-g005.jpg

相似文献

1
Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease.靶向糖胺聚糖在遗传和炎症性气道疾病中的作用。
Int J Mol Sci. 2022 Jun 8;23(12):6400. doi: 10.3390/ijms23126400.
2
Glycosaminoglycans: A Link Between Development and Regeneration in the Lung.糖胺聚糖:肺部发育与再生的联系。
Stem Cells Dev. 2019 Jul 1;28(13):823-832. doi: 10.1089/scd.2019.0009. Epub 2019 Jun 11.
3
Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.硫酸化糖胺聚糖与金属蛋白酶组织抑制剂-3相互作用的结构和功能见解——对细胞外基质稳态的一种可能调节作用
Acta Biomater. 2016 Nov;45:143-154. doi: 10.1016/j.actbio.2016.08.030. Epub 2016 Aug 18.
4
Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.从 bench 到床边的综述:糖胺聚糖在呼吸系统疾病中的作用
Crit Care. 2006;10(6):237. doi: 10.1186/cc5069.
5
Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.成纤维细胞生长阶段的基质糖胺聚糖:伤口愈合中的更多情况
J Surg Res. 2000 Jul;92(1):45-52. doi: 10.1006/jsre.2000.5840.
6
The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.糖胺聚糖在肺部疾病中的“甜蜜”和“苦涩”参与:药物治疗相关性。
Br J Pharmacol. 2009 Aug;157(7):1111-27. doi: 10.1111/j.1476-5381.2009.00279.x. Epub 2009 Jun 5.
7
Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease.糖胺聚糖作为囊性纤维化肺病的多功能抗弹性蛋白酶和抗炎药物
Front Pharmacol. 2020 Jul 8;11:1011. doi: 10.3389/fphar.2020.01011. eCollection 2020.
8
Hypoxia differentially enhances the effects of transforming growth factor-beta isoforms on the synthesis and secretion of glycosaminoglycans by human lung fibroblasts.缺氧对转化生长因子-β亚型影响人肺成纤维细胞合成和分泌糖胺聚糖的作用有不同程度的增强。
J Pharmacol Exp Ther. 2002 Jun;301(3):830-7. doi: 10.1124/jpet.301.3.830.
9
Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.靶向趋化因子-糖胺聚糖相互作用抑制炎症。
Front Immunol. 2020 Mar 31;11:483. doi: 10.3389/fimmu.2020.00483. eCollection 2020.
10
Glycosaminoglycans in cancer therapy.聚糖在癌症治疗中的应用。
Am J Physiol Cell Physiol. 2022 Jun 1;322(6):C1187-C1200. doi: 10.1152/ajpcell.00063.2022. Epub 2022 Apr 6.

引用本文的文献

1
The Genetics behind Sulfation: Impact on Airway Remodeling.硫酸化背后的遗传学:对气道重塑的影响。
J Pers Med. 2024 Feb 25;14(3):248. doi: 10.3390/jpm14030248.
2
Association between SUMF1 polymorphisms and COVID-19 severity.SUMF1 多态性与 COVID-19 严重程度的关联。
BMC Genom Data. 2023 Jun 21;24(1):34. doi: 10.1186/s12863-023-01133-6.
3
Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease.蛋白质组学:发现结缔组织病-间质性肺病发病机制的潜在技术。

本文引用的文献

1
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19.一项关于静脉注射α-1抗胰蛋白酶治疗新型冠状病毒肺炎继发急性呼吸窘迫综合征的随机、双盲、安慰剂对照试验。
Med. 2022 Apr 8;3(4):233-248.e6. doi: 10.1016/j.medj.2022.03.001. Epub 2022 Mar 11.
2
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications.SARS-CoV-2 相关急性呼吸窘迫综合征中蛋白酶-抗蛋白酶的区室化:治疗意义。
EBioMedicine. 2022 Mar;77:103894. doi: 10.1016/j.ebiom.2022.103894. Epub 2022 Feb 22.
3
High-Sulfated Glycosaminoglycans Prevent Coronavirus Replication.
Front Immunol. 2023 Mar 29;14:1146904. doi: 10.3389/fimmu.2023.1146904. eCollection 2023.
高硫酸化糖胺聚糖可预防冠状病毒复制。
Viruses. 2022 Feb 17;14(2):413. doi: 10.3390/v14020413.
4
Glycosaminoglycans in Neurodegenerative Diseases.神经退行性疾病中的糖胺聚糖。
Adv Exp Med Biol. 2021;1325:189-204. doi: 10.1007/978-3-030-70115-4_9.
5
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update.低分子量肝素的抗炎/免疫调节和抗病毒作用:最新进展。
Cardiovasc Drugs Ther. 2023 Apr;37(2):277-281. doi: 10.1007/s10557-021-07251-6. Epub 2021 Aug 30.
6
Alterations in plasma hyaluronic acid in patients with clinically stable COPD versus (non)smoking controls.慢性阻塞性肺疾病(COPD)患者与非吸烟对照者血浆透明质酸的变化。
Sci Rep. 2021 Aug 5;11(1):15883. doi: 10.1038/s41598-021-95030-6.
7
COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction.COVID-19 产生透明质酸片段,直接诱导内皮屏障功能障碍。
JCI Insight. 2021 Sep 8;6(17):e147472. doi: 10.1172/jci.insight.147472.
8
Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain.糖基化的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白N端结构域上假定的糖胺聚糖结合位点的证据。
Comput Struct Biotechnol J. 2021;19:2806-2818. doi: 10.1016/j.csbj.2021.05.002. Epub 2021 May 4.
9
Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients.肝素可防止 COVID-19 患者血浆诱导的体外糖萼脱落。
Life Sci. 2021 Jul 1;276:119376. doi: 10.1016/j.lfs.2021.119376. Epub 2021 Mar 27.
10
Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic.阐明肝素/硫酸乙酰肝素与SARS-CoV-2相关蛋白之间的相互作用——开发针对COVID-19大流行的新型疗法的重要策略。
Front Mol Biosci. 2021 Jan 25;7:628551. doi: 10.3389/fmolb.2020.628551. eCollection 2020.